Warning letter
KPC Products Inc: warning letter of Jun 20, 2018
FDA warning letter 548695 · Los Angeles District Office
Key facts
| Reference number | 548695 |
|---|---|
| Company | KPC Products Inc |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Jun 20, 2018 |
| Posted date | Jun 20, 2018 |
| Issuing office | Los Angeles District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.4, 101.36, 111, 111.70(b), 111.70(b)(1), 111.70(b)(2), 111.70(e), 111.320(a), 111.320(b), 111.75(a)(1)(i), 111.75(a)(1)(ii), 111.75(a)(2) and 1 more |
| Inspection city | Irvine |
| Inspection ZIP | 92618 |
| Inspection start date | Dec 14, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: